These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 18459102)

  • 1. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
    Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
    Kawada M; Inoue H; Arakawa M; Ikeda D
    Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1.
    Degeorges A; Wang F; Frierson HF; Seth A; Chung LW; Sikes RA
    Cancer Res; 1999 Jun; 59(12):2787-90. PubMed ID: 10383131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.
    Rubin J; Chung LW; Fan X; Zhu L; Murphy TC; Nanes MS; Rosen CJ
    Prostate; 2004 Jan; 58(1):41-9. PubMed ID: 14673951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.
    Sakko AJ; Ricciardelli C; Mayne K; Tilley WD; Lebaron RG; Horsfall DJ
    Cancer Res; 2001 Feb; 61(3):926-30. PubMed ID: 11221884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.
    Kawada M; Inoue H; Masuda T; Ikeda D
    Cancer Res; 2006 Apr; 66(8):4419-25. PubMed ID: 16618768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
    Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA
    Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transforming growth factor-beta1 on parathyroid hormone-related protein mRNA expression and protein secretion in canine prostate epithelial, stromal, and carcinoma cells.
    Sellers RS; LeRoy BE; Blomme EA; Tannehill-Gregg S; Corn S; Rosol TJ
    Prostate; 2004 Mar; 58(4):366-73. PubMed ID: 14968437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
    Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
    Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
    Devi GR; Sprenger CC; Plymate SR; Rosenfeld RG
    Prostate; 2002 May; 51(2):141-52. PubMed ID: 11948969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts.
    Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR
    Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
    Song Z; Powell WC; Kasahara N; van Bokhoven A; Miller GJ; Roy-Burman P
    Cancer Res; 2000 Dec; 60(23):6730-6. PubMed ID: 11118059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue.
    Vanveldhuizen PJ; Zulfiqar M; Banerjee S; Cherian R; Saxena NK; Rabe A; Thrasher JB; Banerjee SK
    Oncol Rep; 2003; 10(5):1067-71. PubMed ID: 12883660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
    Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
    Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.